9 Nov 2026 10:00
Beyond Initial Therapy for Hypertension
Many patients continue to have blood pressure above goal despite treatment, creating opportunities for pharmacy teams to support medication use, monitoring, and follow-up. This course reviews the role of recently approved baxdrostat in hypertension management, as well as emerging evidence on the tolerability of antihypertensive therapies and combinations. You will be better prepared to support patients as antihypertensive therapy is intensified.HOSTRachel Maynard, PharmDGameChangers Podcast Host and Lead, Clinical & Partnership Education, CEimpactGUESTEric J MacLaughlin, Pharm.D., BCPSUniversity Distinguished Professor and Chair, Department of Pharmacy Practice, Texas Tech University Health Sciences Center
GET CE FOR LISTENING!Stay Compliant. Grow Clinically. Practice with Confidence.
Purchase a CE Subscription to get CE credit for this episode.
All episodes, CE, and Practice Resources for the GameChangers Clinical Update are included with a Pharmacist or Technician CE Subscription. But wait…there’s even more!
The Pharmacist & Technician CE Subscriptions include: - Compliance and licensure CE - GameChangers Clinical Updates- Practical continuing education across patient care topics
*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.
CEimpact's CE Subscriptions: All your CE in one convenient subscription. Purchase Now!
PRACTICE RESOURCEReceive the exclusive Practice Resource to use as a reference guide for this episode by purchasing a Pharmacist or Technician CE Subscription.
CPE REDEMPTIONThis course is accredited for continuing pharmacy education!
If you have a CE Subscription and are ready to claim credit, click the link below for your practice role:
If you do not have a CE Subscription, click here to purchase and claim credit for this episode!
CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe the role of baxdrostat in hypertension management when blood pressure remains above goal despite treatment.2. Explain practical considerations for medication tolerability, monitoring, and patient education when antihypertensive therapy is intensified.
Eric MacLaughlin is a Consultant for AstraZeneca and CMEVacations. All relevant financial relationships have been mitigated.0.1 CEU/1.0 HrUAN: 0107-0000-26-374-H01-P Initial release date: 11/9/2026Expiration date: 11/9/2029Additional CPE details can be found here for pharmacists and here for pharmacy technicians.
